XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 37,732 $ 14,933
Marketable securities 141,828 167,803
Accounts receivable, net of allowances and reserves of $3,504 and $4,040 as of June 30, 2025 and December 31, 2024, respectively 18,295 28,616
Deferred contract acquisition costs, current 9,362 10,784
Prepaid expenses and other current assets 7,651 6,194
Total current assets 214,868 228,330
Property and equipment, net 5,290 6,673
Operating right-of-use assets 1,603 2,297
Intangible asset, net 450 660
Deferred contract acquisition costs, non-current 11,735 12,199
Other long-term assets 1,170 794
Total assets 235,116 250,953
Current liabilities    
Accounts payable 3,657 2,746
Accrued and other current liabilities 15,206 16,394
Deferred revenue 62,152 66,687
Operating lease liabilities, current 1,113 2,372
Total current liabilities 82,128 88,199
Operating lease liabilities, non-current 925 1,016
Other long-term liabilities 2,046 2,326
Total liabilities 85,099 91,541
Commitments and contingencies (Note 8)
Stockholders’ equity    
Common stock, $0.0001 par value per share; 500,000,000 shares authorized as of June 30, 2025 and December 31, 2024; 42,671,261 and 42,013,694 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively 3 4
Additional paid-in capital 513,601 507,188
Accumulated deficit (363,649) (347,669)
Accumulated other comprehensive income (loss) 62 (111)
Total stockholders’ equity 150,017 159,412
Total liabilities and stockholders’ equity $ 235,116 $ 250,953